ImmunityBioIBRX
那斯達克 · USD
8.32
+0.41
(+5.18%)
盤中 09/15 03:47 (UTC+8)
09/15 03:47 (UTC+8)
ImmunityBioIBRX
8.32
+0.41
(+5.18%)
財務數據
損益表
- 0.00
- 0.01
- 0.06
- 0.08
- 0.17
- 0.26
- 0.32
- 0.38
- 0.44
- 0.51
- -71.22
- 2517.50
- 483.19
- 23.68
- 118.71
- 59.99
- 21.33
- 19.41
- 15.47
- 15.91
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 51,240 | 44,206 | 38,285 | 32,061 | 26,425 | 16,517 | 7,552 | 6,106 | 1,047 | 40 |
營業成本 | 298 | 238 | 382 | 177 | 136 | 58 | - | - | - | - |
營業毛利 | 50,942 | 43,968 | 37,903 | 31,884 | 26,289 | 16,459 | 7,552 | 6,106 | 1,047 | 40 |
營業費用 | 112,639 | 113,759 | 102,586 | 87,514 | 97,574 | 80,888 | 76,952 | 86,359 | - | 95,236 |
研發費用 | 60,816 | 67,989 | 63,857 | 51,232 | 55,236 | 48,234 | 35,221 | 50,443 | 51,129 | 53,351 |
推銷及管理費用 | 51,823 | 45,770 | 38,729 | 36,282 | 42,338 | 32,654 | 41,731 | 35,916 | 49,251 | 41,885 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -61,697 | -69,791 | -64,683 | -55,630 | -71,285 | -64,429 | -69,400 | -80,253 | -99,333 | -95,196 |
其他收入及費用 | -137,449 | -534,533 | 29,782 | 15,905 | 7,864 | -36,606 | 39,820 | 39,738 | -1,222 | -1,447 |
利息費用 | 31,244 | 28,464 | 27,192 | 27,584 | 28,884 | 28,865 | 37,574 | 40,247 | 39,019 | 37,487 |
稅前純益 | -230,390 | -632,788 | -62,093 | -67,309 | -92,305 | -129,900 | -59,179 | -85,752 | -134,584 | -134,130 |
所得稅 | - | 9 | -135 | -35 | 269 | -234 | - | - | - | - |
稅後純益 | -230,378 | -632,782 | -61,944 | -67,253 | -92,555 | -129,646 | -59,162 | -85,729 | -134,564 | -134,109 |
基本每股稅後盈餘(元) | -0.22 | -0.62 | -0.06 | -0.07 | -0.10 | -0.15 | -0.08 | -0.12 | -0.20 | -0.20 |
稀釋每股稅後盈餘(元) | -0.21 | -0.62 | -0.06 | -0.06 | -0.11 | -0.15 | -0.09 | -0.13 | -0.20 | -0.20 |
基本平均股數(千股) | 1050070.00 | 1026874.00 | 989679.00 | 946601.00 | 888216.00 | 853162.00 | 733204.00 | 695895.00 | 686938.00 | 672831.00 |
稀釋平均股數(千股) | 1050070.00 | 1026874.00 | 989679.00 | 946601.00 | 888216.00 | 853162.00 | 734542.00 | 697961.00 | 686938.00 | 672831.00 |
還原基本每股稅後盈餘(元) | -0.22 | -0.62 | -0.06 | -0.07 | -0.10 | -0.15 | -0.08 | -0.12 | -0.20 | -0.20 |
還原稀釋每股稅後盈餘(元) | -0.21 | -0.62 | -0.06 | -0.06 | -0.11 | -0.15 | -0.09 | -0.13 | -0.20 | -0.20 |
還原基本平均股數(千股) | 1,050,070 | 1,026,874 | 989,679 | 946,601 | 888,216 | 853,162 | 733,204 | 695,895 | 686,938 | 672,831 |
還原稀釋平均股數(千股) | 1,050,070 | 1,026,874 | 989,679 | 946,601 | 888,216 | 853,162 | 734,542 | 697,961 | 686,938 | 672,831 |
EBITDA(千元) | -196,999 | -601,455 | -32,726 | -36,731 | -59,533 | -97,238 | -12,467 | -35,408 | -85,701 | -87,009 |